Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The impact of GPT2 deficiency on gene expression in ovarian cancer cells

ABSTRACT: The impact of GPT2 deficiency on gene expression in ovarian cancer cells

PROVIDER: PRJNA1280929 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR34136237_1.fastq.gz	Fastqsanger.gz
	SRR34136237_2.fastq.gz	Fastqsanger.gz
	SRR34136238_1.fastq.gz	Fastqsanger.gz
	SRR34136238_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 5

Similar Datasets

The impact of U2AF2 deficiency on gene expression in ovarian cancer cells

Project description:The impact of U2AF2 deficiency on gene expression in ovarian cancer cells

| PRJNA1247880 | ENA

The impact of NR1H3 deficiency on gene expression in ovarian cancer cells

Project description:The impact of NR1H3 deficiency on gene expression in ovarian cancer cells

| PRJNA1244420 | ENA

The impact of U2AF2 deficiency on gene expression in ovarian cancer cells

Project description:U2AF2 is an RNA processing-related factor that has a substantial impact on various cellular processes and is also closely associated with cancer development.Here, functional experiments demonstrated that U2AF2 significantly promotes ovarian cancer progression.RNA-seq analysis revealed that differentially expressed genes downstream of U2AF2 are significantly enriched in the Wnt signaling pathway, which was validated by Western blot.In summary, our data provide new molecular insights into ovarian cancer.

2026-01-21 | GSE294020 | GEO

The impact of NR1H3 deficiency on gene expression in ovarian cancer cells

Project description:NR1H3 is significantly influences cancer progression. Here, we identified the critical role of NR1H3 in the diagnosis and prognosis of ovarian cancer through bioinformatics analysis. Further functional experiments demonstrated that NR1H3 significantly promotes ovarian cancer progression through RPL29. RNA-seq analysis revealed that differentially expressed genes downstream of NR1H3 are significantly enriched in the TNF signaling pathway, which was validated by Western blot. In summary, our data provide new molecular insights into ovarian cancer.

2025-04-03 | GSE293430 | GEO

The impact of GPT2 deficiency on gene expression in ovarian cancer cells

Project description:Here, functional experiments demonstrated that GPT2 significantly promotes ovarian cancer progression.RNA-seq analysis revealed that differentially expressed genes downstream of GPT2 are significantly enriched in the TNF signaling pathway, which was validated by Western blot.In summary, our data provide new molecular insights into ovarian cancer.

2025-06-26 | GSE300422 | GEO

Effect of SRMS deficiency on gene expression upon cisplatin treatment in human ovarian cancer cells

Project description:This study was designed to evaluate the transcriptomic alterations upon SRMS deficiency after cisplatin exposure in a human ovarian cancer cell line.

2023-06-07 | GSE206226 | GEO

Gene expression of Ovarian Cancer

Project description:Gene expression of Ovarian Cancer

| PRJNA754050 | ENA

Gene expression in ovarian cancer

Project description:Gene expression in ovarian cancer

| PRJNA129963 | ENA

Impact of genetic depletion or pharmacological inhibition of LSD1 on gene expression in ovarian cancer cells [CUT&Tag]

Project description:LSD1 is frequently overexpressed and correlates with poor prognosis in patients with ovarian cancer. RNA-seq, CUT&Tag-seq and ATAC-seq were performed to determine the impact of genetic depletion or pharmacological inhibition of LSD1 on gene expresion profiles in ovarian cancer cells.

2023-10-20 | GSE218796 | GEO

Impact of genetic depletion or pharmacological inhibition of LSD1 on gene expression in ovarian cancer cells [ATAC-Seq]

2023-10-20 | GSE218795 | GEO